Bone marrow suppression or active proliferation? An analysis of neutropenia after pegylated interferon treatment of patients with chronic hepatitis C

Author： Liu Ya-Li Du Xiao-Fei Chen Xin-Yue Ma Li-Na Guo Dan-Dan Lu Jun-Feng Cao Zhen-Huan Zhang Yong-Hong

Publisher： Informa Healthcare

ISSN： 0036-5548

Source： Scandinavian Journal of Infectious Diseases, Vol.45, Iss.12, 2013-12, pp. : 939-943

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dyspnoea in patients with chronic hepatitis C treated with pegylated interferon and ribavirin

By Garib Junia Rios Garcia Guilherme Freire Teixeira Rosâângela Lima e Silva Francisco das Chagas

Scandinavian Journal of Infectious Diseases, Vol. 43, Iss. 8, 2011-08 ,pp. : 625-631

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Tolerability of Pegylated Interferon-α_2a plus Ribavirin versus Pegylated Interferon-α_2b plus Ribavirin in Treatment-Naive Chronic Hepatitis C Patients

Intervirology, Vol. 53, Iss. 3, 2010-01 ,pp. : 146-153

Karger

Access to resources Recommend Favorite

Influence of Host and Viral Factors on Patients with Chronic Hepatitis C Virus Genotype 6 Treated with Pegylated Interferon and Ribavirin: A Systematic Review and Meta-Analysis

Intervirology, Vol. 58, Iss. 6, 2016-03 ,pp. : 373-381

Karger

Access to resources Recommend Favorite

Treatment of Acute Hepatitis C Infection with Pegylated Interferon and Ribavirin in Patients Coinfected with Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis

Intervirology, Vol. 58, Iss. 4, 2015-0 ,pp. : 242-249

Karger

Access to resources Recommend Favorite

Meta-Analysis: Superior Treatment Response in Asian Patients with Hepatitis C Virus Genotype 6 versus Genotype 1 with Pegylated Interferon and Ribavirin

Intervirology, Vol. 58, Iss. 1, 2015-01 ,pp. : 27-34

Karger

Access to resources Recommend Favorite